FCM Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-53,407
Closed -$3.63M 63
2017
Q1
$3.63M Sell
53,407
-1,550
-3% -$109K 2.29% 13
2016
Q4
$3.94M Sell
54,957
-4,450
-7% -$331K 2.38% 14
2016
Q3
$4.7M Sell
59,407
-750
-1% -$60.9K 2.63% 11
2016
Q2
$5.02M Sell
60,157
-2,231
-4% -$198K 2.98% 11
2016
Q1
$5.73M Sell
62,388
-3,750
-6% -$338K 3.05% 9
2015
Q4
$6.69M Buy
66,138
+6,600
+11% +$687K 3.47% 7
2015
Q3
$5.85M Sell
59,538
-862
-1% -$95.7K 2.88% 8
2015
Q2
$7.07M Sell
60,400
-800
-1% -$87.4K 3.37% 7
2015
Q1
$6.01M Buy
61,200
+400
+0.7% +$40.6K 2.9% 8
2014
Q4
$5.73M Sell
60,800
-700
-1% -$72.4K 2.69% 10
2014
Q3
$6.55M Buy
61,500
+60,300
+5,025% +$5.9M 2.98% 7
2014
Q2
$99K Buy
+1,200
New +$93.4K 0.05% 76
2014
Q1
Sell
-400
Closed -$30K 102
2013
Q4
$30K Hold
400
0.01% 104
2013
Q3
$25K Sell
400
-400
-50% -$23.9K 0.01% 102
2013
Q2
$41K Buy
+800
New +$41.7K 0.02% 102

Other funds holding GILD

FCM Investments's GILD Position: Q2 2017 in Review

FCM Investments sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 53,407 shares — an estimated $3.63M sold.

FCM Investments first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $7.07M in Q2 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • FCM Investments reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • FCM Investments sold 53,407 Gilead Sciences shares in Q2 2017, an estimated $3.63M.
  • FCM Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • FCM Investments's Gilead Sciences position peaked at $7.07M in Q2 2015.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.